Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breastcancer. "We achieved key milestones during the quarter against our ... of the liver and is not typically detected early, often resulting in a poor patient prognosis. Globally, primary liver cancer is one of the most deadly forms of cancer and ranks as ...
2009 NOV 23 ... high-quality specimens is good. Today, all types of colorectal and breast tumors along with kidney cancers are included. James Robb, M.D., FACH, consulting ... Christiana Care Health System's Helen F. Graham Cancer Center became the first community hospital in the nation to submit specimens to the ... only three types of tumors: brain, ovary and lung. The NCI chose these three because the prognosis for patients with these types of tumors is poor and the likelihood of obtaining ...
2009 NOV 16 ... F-18-FDG PET/CT in predicting response to neoadjuvant chemotherapy in large primary breastcancer. Fifty consecutive patients underwent PET/CT at baseline and after the second ... considered responders and ten as non-responders. SUVmax changes in patients with good prognosis (M&P grades 4-5) were higher than in patients with bad prognosis (M& P grades 1-3) (p= ...
2009 NOV 16 ... polymorphisms as potential genetic markers to predict the development and prognosis of breastcancer." "The incidence of R72P, PIN3 Ins 16bp and PIN6 G13494A ...
2009 NOV 16 ... and their prognostic clinical value, we investigated tumour samples of 311 patients with breastcancer by immunohistochemistry. TRAIL receptor expression profiles were correlated with ... differentiated tumours, and correlated positively with surrogate markers of a better prognosis (hormone receptor status, Bcl-2, negative nodal status), but negatively with the ...
2009 NOV 16 ... from the report, 'High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant ... treated with adjuvant chemotherapy,' have been published. "Triple-negative breast cancer (TNBC) is an aggressive disease, nevertheless exhibiting a high response rate to ...
2009 NOV 23 ... Park, Abingdon, Oxford OX14 4RN United Kingdom. Keywords: Korea, Seoul, Breast Cancer Prognosis, Breast Cancer, Breast Carcinoma, Magnetic Resonance, Oncology, Radiology, Women's ...
2009 NOV 23 ... Research findings, 'The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression,' are discussed in a new report. ... New York, NY 10010-1707, USA. Keywords: United States, Baltimore, Breast Cancer, Breast Carcinoma, Diagnosis, Diagnostics, Ductal Carcinoma, Genetics, Germ Cell Cancer, ... suggests a possible common underlying mechanism. This telomere phenotype confers a poor prognosis in some cancers; two of the three cases in our study showed rapid tumor progression, ...
2009 NOV 16 ... The treatment of breastcancer is one of the most rapidly evolving areas of medical oncology. Of greatest ... which is increasing our understanding of gene profiles for assessing a patient's prognosis, as well as predicting how a patient will respond to chemotherapy. New and mounting ...
2009 NOV 16 ... 233 Spring Street, New York, NY 10013, USA. Keywords: Italy, Rome, Breast Cancer Prognosis, Biopsy, Bone Marrow, Breast Cancer, Breast Carcinoma, Carcinoembryonic Antigen, ...
2009 NOV 23 ... of the human epidermal growth factor receptor 2 (HER2) is amplified in 25% to 30% of breast cancers and has been associated with an unfavorable prognosis. Here we report the ... For additional information, contact J. Capala, National Cancer Institute, Center Cancer Research, National Institutes of Health, 10 Center Dr., Bldg ...
2009 NOV 23 ... methotrexate and 5-fluorouracile (CMF)-based chemotherapy for adjuvant treatment of breastcancer reduces the risk of relapse. In this exploratory study, we tested the feasibility ... profile is chemotherapy-specific or whether it is a more general indicator of bad prognosis of breast cancer patients remains to be explored." Specht and colleagues ...
2009 NOV 23 ... is overexpressed in adenocarcinomas, are associated with good prognosis in patients with breastcancer. The aim of the present investigation was to determine whether GM and KM ...
2009 NOV 16 ... of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breastcancer cell proliferation,' new data in cancer gene therapy. According to recent ... data provide an explanation as to why high trkA levels are associated with favourable prognosis." Montano and colleagues published their study in Oncogene (Repression of ...
2009 NOV 16 ... According to a study from the United States, "Brain metastases of breastcancer seem to be increasing in incidence as systemic therapy improves. Metastatic ... of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis. Molecular Cancer Research, 2009;7(9):1438-1445). For additional ...
2009 NOV 23 ... "Squamous cell carcinoma (SCC) of the breast is an uncommon breast neoplasm. There are limited data about its epidemiology and few ... hundred and seventy-seven cases of SCC of the breast were identified in the California Cancer Registry from the years 1988 to 2006. At the time of diagnosis, 53 per cent of patients ... patients with breast SCC, investigate its natural history, and determine its long-term prognosis. One hundred and seventy-seven cases of SCC of the breast were identified in the ...
2009 NOV 16 ... of CD24 expression by immunohistochemistry was 68% in all the carcinomas of the breast, female genital tract, gastrointestinal tract, biliary tract and pancreas, urinary ... P<0.001). CD24 expression was highly associated with lymph node metastases in breast cancer (OR=3.55; 95% CI, 1.664-7.554; P=0.001), advanced clinical stages (OR=2.22; 95% CI, ... strongly supports the idea that CD24 is an important marker of malignancy and poor prognosis in various cancers. In particular, CD24 may promote cancer development and progression ...
2009 NOV 23 ... "Traditional prognostic markers for breastcancer include estrogen receptor (ER), progesterone receptor (ER) and HER2/neu. Negative ... wrote S. Nofechmozes and colleagues. The researchers concluded: "The prognosis of these women may be superior to that of basal-like breast cancers but firm conclusions ...
2009 NOV 16 ... prognosis in many carcinomas. However, limited information about its expression in breastcancer tissue is available." "Therefore, we carried out an analysis on L1 ...
2009 NOV 23 ... According to recent research published in the journal BreastCancer Research and Treatment, "The p53 tumor suppressor gene has a central role in the ... since we found that loss of this allele was associated with earlier onset and worse prognosis." Wegman and colleagues published their study in Breast Cancer Research ...
